Chemohormonal therapy for malignant melanomas

Journal of Otolaryngology of Japan

Volumn 99, Issue 7, 1996, Pages 1004-1009

  Seo, Wataru ^a   Ogasawara, Hiroshi ^a   Sakagami, Masafumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CISPLATIN; DACARBAZINE; RANIMUSTINE; TAMOXIFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MELANOMA;

EID: 0029902363     PISSN: 00306622     EISSN: None     Source Type: Journal    
DOI: 10.3950/jibiinkoka.99.1004     Document Type: Article

References (20)

1. McClay EF, Masarangelo MJ, Bread D, Bellet RE : Effective combination chemohormonal therapy for malignant melanoma. INT J Cancer: 50 553-556, 1992.
2. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcatera TC: Mucosal melanoma of the head and neck. The impact of local control on survival: Laryngoscope 104: 121-126, 1994.
3. Stern SJ, Guillamondegui OM: Mucosal melanoma of the head and neck. Head neck Surg 13: 22-27, 1991.
4. Houghton AN, Legha S, Bajorin DF: Chemotherapy for metastatic melanoma. Lipiimcott Co. Philadelphia: pp 198-508, 1992.
5. Cartin D: Mucosal melanomas of the head and neck. Am J Roentgenol 99: 809-816, 1967.
6. Del Prete SA, Maurer LH, O'Donnell J, Jackson R: Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 68: 1403-1405, 1984.
7. Nesbit RA, Woods RL, Tatrersall MH, Richard MF: Tamoxifen in malignant melanoma. N Eng J Med 301: 1241, 1979.
8. Mirimanoff RO, Wagenknecht L, Hunziker N: Long term complete remission of malignant melanoma with tamoxifen. Lancet 1: 1368-1369, 1981.
9. Lippman ME, Dickson RB, Bates S: Autocrine and Paracurine growth regulation of human breast cancer. Brest Cancer Res Treat 1: 59-70, 1986.
10. Allegra JC. Lippman ME: Estrogen receptor status: Eur J Cancer 16: 323-331, 1980.
11. Kiag DT, Frening DH, Goldman AI: Estrogen receptors and responses to chemotherapy and hormonal therapy in breast cancer. N Engl J Med 299: 1330-1334, 1978.
12. Sitteri PK, Nisker JK, Hammond GL: Hormonal basis of risk factors for breast cancer. Hormones and cancer. Raven Press: pp 499-506, 1980.
13. Jonk A, Kroon BB, Rumke PH, McCarty KS: Lymph node metastasis from melanoma. Br J Surg 77: 665-668, 1990.
14. Davis NC, McLeod R, Beardmore JC, Walsh D: Primary melanoma: A report from the Queensland melanoma project. Cancer 26: 80-107, 1976.